[Efficacy of a bendamustine and rituximab combination in first-line therapy for chronic lymphocytic leukemia: Results of the BEN-001 study]. [electronic resource]
Producer: 20171129Description: 57-64 p. digitalISSN:- 0040-3660
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Bendamustine Hydrochloride -- administration & dosage
- Female
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm, Residual -- diagnosis
- Quality of Life
- Remission Induction -- methods
- Rituximab -- administration & dosage
- Russia -- epidemiology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.